Conversion of Loan Notes in Paraytec Limited

RNS Number : 6778B
Braveheart Investment Group plc
24 September 2018
 

24 September 2018

 

 

Braveheart Investment Group plc

("Braveheart" or the "Company")

 

Conversion of loan note results in majority interest in Paraytec Limited

 

Braveheart Investment Group plc (AIM:BRH), the fund management and strategic investor group, is pleased to announce that following the conversion of £89,655 of loan notes previously advanced to Paraytec Limited ("Paraytec") into 20,582 Paraytec A ordinary shares, Braveheart now holds, in aggregate, 56.5 per cent. of the currently issued share capital of Paraytec. 

At the same time as the conversion of £89,655 of loan notes mentioned above, other third party holders of £16,400 of loan notes also converted such loan notes into A ordinary shares.

In the year ended 31 October 2017, Paraytec incurred a loss after tax of £74,174 and at that date had net liabilities of £143,772 (including the £106,055 of loan notes mentioned above).

In the Chief Executive Officer's Report in the accounts for the year ended 31 March 2018, the following operational update was provided on Paraytec: "In 2017 Paraytec took action to focus its business activities and reduce its fixed cost base. Its objective was to ensure the business was profitable based on the royalty income stream from its two main licensees - Malvern Panalytical Ltd and Pion Inc. Concurrently, the company commenced two, key grant funded, R&D projects to develop new product lines for the future. This strategy worked well and the business is now profitable and cash positive."

 

For further information:

 

Braveheart Investment Group plc
Viv Hallam, Executive Director

 

Tel: 01738 587555

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)
David Worlidge / Nicholas Chambers

 

 

Tel: 020 3328 5656

 

Peterhouse Capital Limited (Joint Broker)
Heena Karani / Lucy Williams

 

 

Tel: 020 7469 0936

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CONDZLBLVKFEBBX
UK 100

Latest directors dealings